TYRA
HealthcareTyra Biosciences, Inc.
$37.71-0.21 (-0.55%)
Prev Close
$37.92
Open
$37.56
High
$38.53
Low
$36.49
Volume
896.6K
Market Cap
$1.82B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Tyra Biosciences, Inc. (TYRA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 8 insider sales totaling $8.64M. The most recent insider transaction was by Bensen Daniel (officer: Chief Discovery Officer), who sold $263.0K worth of shares on Feb 13, 2026. Tyra Biosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.82B.
Buys (12M)
0
$0.00
Sells (12M)
8
$8.64M
Net Activity
Net Seller
$8.64M
Active Insiders
3
last 12 mo
TYRA Price Chart
TYRA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026↗ | Bensen Daniel | officer: Chief Discovery Officer | Sell | 8,000 | $32.87 | $263.0K | 152,853 |
| Jan 20, 2026↗ | Bensen Daniel | officer: Chief Discovery Officer | Sell | 8,000 | $28.52 | $228.2K | 155,998 |
| Jan 12, 2026↗ | Bensen Daniel | Chief Discovery Officer | Sell | 8,000 | $28.52 | $228.2K | 0 |
| Dec 12, 2025↗ | Bensen Daniel | Chief Discovery Officer | Sell | 8,000 | $22.64 | $181.2K | 0 |
| Nov 21, 2025↗ | MORE ROBERT J | Director | Sell | 246,871 | $20.25 | $5.00M | 0 |
| Nov 13, 2025↗ | Bensen Daniel | Chief Operating Officer | Sell | 131,411 | $16.04 | $2.11M | 0 |
| Jun 17, 2025↗ | KAPLAN GILLA | Director | Sell | 9,578 | $9.78 | $93.7K | 0 |
| Jun 12, 2025↗ | KAPLAN GILLA | Director | Sell | 51,814 | $10.32 | $534.6K | 0 |
| Feb 7, 2025↗ | Kjellson Nina S | Sell | 5,401 | $13.76 | $74.3K | 3,700,700 | |
| Jan 27, 2025↗ | Kjellson Nina S | Sell | 4,825 | $16.26 | $78.5K | 3,702,600 | |
| Jan 21, 2025↗ | Kjellson Nina S | Sell | 25,041 | $16.36 | $409.6K | 3,724,220 | |
| Nov 26, 2024↗ | Kjellson Nina S | Sell | 5,272 | $16.84 | $88.8K | 3,731,160 | |
| Nov 13, 2024↗ | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,220,681 | $16.25 | $19.84M | 8,697,960 | |
| Nov 8, 2024↗ | Kjellson Nina S | Sell | 74,582 | $17.22 | $1.28M | 3,755,590 | |
| Nov 6, 2024↗ | Kjellson Nina S | Sell | 11,569 | $16.79 | $194.2K | 3,811,810 | |
| Nov 1, 2024↗ | Fuhrman Alan | Chief Financial Officer | Buy | 9,500 | $16.00 | $152.0K | 12,849 |
| Nov 1, 2024↗ | Kjellson Nina S | Sell | 138,107 | $16.45 | $2.27M | 3,926,710 | |
| Oct 22, 2024↗ | Harris Todd | President and CEO | Sell | 62,720 | $27.28 | $1.71M | 1,375,010 |
| Oct 17, 2024↗ | Harris Todd | President and CEO | Sell | 58,726 | $25.77 | $1.51M | 1,467,340 |
| Oct 2, 2024↗ | Harris Todd | President and CEO | Sell | 500 | $24.00 | $12.0K | 1,477,370 |
| Sep 25, 2024↗ | Harris Todd | President and CEO | Sell | 11,747 | $24.11 | $283.2K | 1,479,530 |
| Sep 20, 2024↗ | Harris Todd | President and CEO | Sell | 16,307 | $24.19 | $394.4K | 1,502,430 |
| Jun 10, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 3,702 | $20.00 | $74.0K | 431,483 |
| Mar 13, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 200 | $20.00 | $4.0K | 431,683 |
| Mar 8, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 1,801 | $20.09 | $36.2K | 431,951 |
| Mar 5, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 9,152 | $20.06 | $183.6K | 439,936 |
| Feb 29, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 8,644 | $20.09 | $173.6K | 450,735 |
| Feb 14, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 1,501 | $20.00 | $30.0K | 451,480 |
| Feb 9, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 9,587 | $18.09 | $173.5K | 452,981 |
| Feb 6, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 90,806 | $16.63 | $1.51M | 480,281 |
| Feb 6, 2024↗ | Harris Todd | President and CEO | Sell | 100,000 | $16.56 | $1.66M | 1,523,700 |
| Jul 21, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 4,107 | $16.01 | $65.8K | 527,981 |
| Jul 17, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 2,400 | $16.05 | $38.5K | 527,981 |
| Jul 12, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 1,903 | $16.03 | $30.5K | 527,981 |
| Jul 3, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 40,365 | $16.70 | $674.2K | 528,381 |
| Jun 28, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 46,784 | $16.86 | $788.6K | 536,116 |
| Jun 26, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 24,190 | $17.01 | $411.5K | 1,622,490 |
| Jun 21, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 75,810 | $17.12 | $1.30M | 1,697,960 |
| Jun 15, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 18,340 | $16.11 | $295.4K | 527,981 |
| Jun 15, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 20,700 | $16.08 | $332.9K | 1,701,280 |
| Apr 5, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 2,000 | $16.13 | $32.3K | 1,701,280 |
| Apr 3, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 4,400 | $16.07 | $70.7K | 527,981 |
| Mar 31, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 4,327 | $16.07 | $69.6K | 1,701,280 |
| Mar 29, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 13,581 | $16.03 | $217.8K | 527,981 |
| Mar 28, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 5,912 | $16.00 | $94.6K | 1,701,280 |
| Mar 23, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 22,727 | $16.00 | $363.6K | 527,981 |
| Mar 23, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 19,236 | $16.00 | $307.8K | 1,701,280 |
| Feb 13, 2023↗ | MVA Investors, LLC | Sell | 265,568 | $13.17 | $3.50M | 88,095 | |
| Dec 21, 2021↗ | Boxer Capital, LLC | 10% Owner | Buy | 125,000 | $13.12 | $1.64M | 6,448,360 |
| Sep 21, 2021↗ | Cormorant Asset Management, LP | Buy | 312,500 | $16.00 | $5.00M | 1,069,930 |
Showing 1–50 of 53
1 / 2
TYRA Insider Buying Activity
The following table shows recent insider purchases of Tyra Biosciences, Inc. (TYRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2024↗ | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,220,681 | $16.25 | $19.84M | 8,697,960 | |
| Nov 1, 2024↗ | Fuhrman Alan | Chief Financial Officer | Buy | 9,500 | $16.00 | $152.0K | 12,849 |
| Dec 21, 2021↗ | Boxer Capital, LLC | 10% Owner | Buy | 125,000 | $13.12 | $1.64M | 6,448,360 |
| Sep 21, 2021↗ | Cormorant Asset Management, LP | Buy | 312,500 | $16.00 | $5.00M | 1,069,930 |
TYRA Insider Selling Activity
The following table shows recent insider sales of Tyra Biosciences, Inc. (TYRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026↗ | Bensen Daniel | officer: Chief Discovery Officer | Sell | 8,000 | $32.87 | $263.0K | 152,853 |
| Jan 20, 2026↗ | Bensen Daniel | officer: Chief Discovery Officer | Sell | 8,000 | $28.52 | $228.2K | 155,998 |
| Jan 12, 2026↗ | Bensen Daniel | Chief Discovery Officer | Sell | 8,000 | $28.52 | $228.2K | 0 |
| Dec 12, 2025↗ | Bensen Daniel | Chief Discovery Officer | Sell | 8,000 | $22.64 | $181.2K | 0 |
| Nov 21, 2025↗ | MORE ROBERT J | Director | Sell | 246,871 | $20.25 | $5.00M | 0 |
| Nov 13, 2025↗ | Bensen Daniel | Chief Operating Officer | Sell | 131,411 | $16.04 | $2.11M | 0 |
| Jun 17, 2025↗ | KAPLAN GILLA | Director | Sell | 9,578 | $9.78 | $93.7K | 0 |
| Jun 12, 2025↗ | KAPLAN GILLA | Director | Sell | 51,814 | $10.32 | $534.6K | 0 |
| Feb 7, 2025↗ | Kjellson Nina S | Sell | 5,401 | $13.76 | $74.3K | 3,700,700 | |
| Jan 27, 2025↗ | Kjellson Nina S | Sell | 4,825 | $16.26 | $78.5K | 3,702,600 | |
| Jan 21, 2025↗ | Kjellson Nina S | Sell | 25,041 | $16.36 | $409.6K | 3,724,220 | |
| Nov 26, 2024↗ | Kjellson Nina S | Sell | 5,272 | $16.84 | $88.8K | 3,731,160 | |
| Nov 8, 2024↗ | Kjellson Nina S | Sell | 74,582 | $17.22 | $1.28M | 3,755,590 | |
| Nov 6, 2024↗ | Kjellson Nina S | Sell | 11,569 | $16.79 | $194.2K | 3,811,810 | |
| Nov 1, 2024↗ | Kjellson Nina S | Sell | 138,107 | $16.45 | $2.27M | 3,926,710 | |
| Oct 22, 2024↗ | Harris Todd | President and CEO | Sell | 62,720 | $27.28 | $1.71M | 1,375,010 |
| Oct 17, 2024↗ | Harris Todd | President and CEO | Sell | 58,726 | $25.77 | $1.51M | 1,467,340 |
| Oct 2, 2024↗ | Harris Todd | President and CEO | Sell | 500 | $24.00 | $12.0K | 1,477,370 |
| Sep 25, 2024↗ | Harris Todd | President and CEO | Sell | 11,747 | $24.11 | $283.2K | 1,479,530 |
| Sep 20, 2024↗ | Harris Todd | President and CEO | Sell | 16,307 | $24.19 | $394.4K | 1,502,430 |
| Jun 10, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 3,702 | $20.00 | $74.0K | 431,483 |
| Mar 13, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 200 | $20.00 | $4.0K | 431,683 |
| Mar 8, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 1,801 | $20.09 | $36.2K | 431,951 |
| Mar 5, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 9,152 | $20.06 | $183.6K | 439,936 |
| Feb 29, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 8,644 | $20.09 | $173.6K | 450,735 |
| Feb 14, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 1,501 | $20.00 | $30.0K | 451,480 |
| Feb 9, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 9,587 | $18.09 | $173.5K | 452,981 |
| Feb 6, 2024↗ | Bensen Daniel | Chief Operating Officer | Sell | 90,806 | $16.63 | $1.51M | 480,281 |
| Feb 6, 2024↗ | Harris Todd | President and CEO | Sell | 100,000 | $16.56 | $1.66M | 1,523,700 |
| Jul 21, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 4,107 | $16.01 | $65.8K | 527,981 |
| Jul 17, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 2,400 | $16.05 | $38.5K | 527,981 |
| Jul 12, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 1,903 | $16.03 | $30.5K | 527,981 |
| Jul 3, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 40,365 | $16.70 | $674.2K | 528,381 |
| Jun 28, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 46,784 | $16.86 | $788.6K | 536,116 |
| Jun 26, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 24,190 | $17.01 | $411.5K | 1,622,490 |
| Jun 21, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 75,810 | $17.12 | $1.30M | 1,697,960 |
| Jun 15, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 18,340 | $16.11 | $295.4K | 527,981 |
| Jun 15, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 20,700 | $16.08 | $332.9K | 1,701,280 |
| Apr 5, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 2,000 | $16.13 | $32.3K | 1,701,280 |
| Apr 3, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 4,400 | $16.07 | $70.7K | 527,981 |
| Mar 31, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 4,327 | $16.07 | $69.6K | 1,701,280 |
| Mar 29, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 13,581 | $16.03 | $217.8K | 527,981 |
| Mar 28, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 5,912 | $16.00 | $94.6K | 1,701,280 |
| Mar 23, 2023↗ | Bensen Daniel | Chief Operating Officer | Sell | 22,727 | $16.00 | $363.6K | 527,981 |
| Mar 23, 2023↗ | Harris Todd | Chief Executive Officer | Sell | 19,236 | $16.00 | $307.8K | 1,701,280 |
| Feb 13, 2023↗ | MVA Investors, LLC | Sell | 265,568 | $13.17 | $3.50M | 88,095 |
TYRA Insiders
Similar Stocks to TYRA
VRTX
Vertex Pharmaceuticals Incorporated
$452.29-2.20%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$745.34-1.66%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$317.24-0.96%
$42.07B
INSM
Insmed Incorporated
$143.85-0.06%
$30.07B
UTHR
United Therapeutics Corporation
$531.23-1.63%
$23.50B
MRNA
Moderna, Inc.
$52.27-3.15%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.86-1.55%
$20.08B
RPRX
Royalty Pharma plc
$45.94-0.36%
$19.56B